Bayer: signs drug commercialization deal in China

(CercleFinance.com) - German chemicals and pharmaceuticals group Bayer has inked a deal with Chinese online pharmacy network 111 to collaborate on drug commercialization in China.


Under the terms of the strategic partnership, 111's omni-channel platform will support Bayer's existing sales and marketing network, the companies said on Monday.

Bayer will leverage 111's network of pharmacies and healthcare providers to broaden its channel management and patient outreach capabilities, as well as increase its market presence in underserved markets in China's smaller cities.

As part of the partnership, Bayer and 111 will also jointly develop a digitalized content portal that will provide online pharmacist training and interactive patient education content and services.

Copyright (c) 2020 CercleFinance.com. All rights reserved.